APC	Antigen-presenting cell
ATV-NDV	NDV-modified autologous tumor cell vaccine
BM	Bone marrow
CIS	Central Immune System
CNS	Central Nervous System
CTL	Cytolytic T lymphocyte
CTLP	Precursor of a CTL
DAMP	Damage-associated molecular pattern
DR	Dietary restriction
ECA	External control arm
EV	Extracellular microvessel
GBM	Glioblastoma multiforme
HBV	Hepatitis B Virus
HCV	Hepatitis C Virus
HMGB1	High mobility group box 1 protein
HN	Hemagglutinin-Neuraminidase protein
HIV	Human Immunodeficiency Virus
HSP	Heat-Shock protein
ICB	Immune Checkpoint Blockade
ICD	Immunogenic Cell Death
IDH1	Isocitrate Dehydrogenase 1
IFN-I	Type I Interferon; Interferon a,ß
IOZK	Immune-Oncological Center Cologne
IO-VACR	NDV-modified individualized dendritic cell vaccine
mEHT	Modulated Electrohyperthermia
MGMT	O6-methylguanine-DNA-methyltransferase
MHC	Major Histocompatibility Complex
MTC	Memory T Cell
NDV	Newcastle Disease Virus
NO	Nitric Oxide
NSA	Non-self Antigen
OS	Overall Survival
OV	Oncolytic Virus
PAMP	Pathogen-associated Molecular Pattern
PRR	Pattern-Recognition Receptor
RCT	Randomized Controlled Study
RIG-I	Retinoic acid inducible Gene I
RLR	RIG-I-like Receptor
RWD	Real World Data
TA	Tumor Antigen
TLS	Tertiary Lymphnode-like Structures
TME	Tumor Microenvironment
TMZ	Temozolomide
TNF	Tumornecrosis Factor
TRAIL	TNF-Related Apoptosis-Inducing Ligand
VOL	Viral Oncolysate